Justin Anglin

Affiliations: 
Calibr 
Google:
"Justin Anglin"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Modukuri RK, Yu Z, Tan Z, et al. (2022) Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proceedings of the National Academy of Sciences of the United States of America. 119: e2122506119
Taylor DM, Anglin J, Hu L, et al. (2021) Unique Diacidic Fragments Inhibit the OXA-48 Carbapenemase and Enhance the Killing of Producing OXA-48. Acs Infectious Diseases
Yu Z, Ku AF, Anglin JL, et al. (2021) Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. Proceedings of the National Academy of Sciences of the United States of America. 118
Lucki NC, Villa GR, Vergani N, et al. (2019) A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer. Proceedings of the National Academy of Sciences of the United States of America
Holt MC, Assar Z, Beheshti Zavareh R, et al. (2018) Biochemical Characterization and Structure-based Mutational Analysis Provides Insight into Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors. Biochemistry
Anglin J, Zavareh RB, Sander PN, et al. (2018) Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorganic & Medicinal Chemistry Letters
Lum KM, Sato Y, Beyer BA, et al. (2017) Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics. Acs Chemical Biology
Mullarky E, Lucki NC, Beheshti Zavareh R, et al. (2016) Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proceedings of the National Academy of Sciences of the United States of America
Anglin JL, Song Y. (2013) A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L. Journal of Medicinal Chemistry. 56: 8972-83
Zheng B, Yao Y, Liu Z, et al. (2013) Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase. Acs Medicinal Chemistry Letters. 4: 542-546
See more...